| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11892-009-0034-5 |
| P698 | PubMed publication ID | 19490822 |
| P50 | author | Morris J. Birnbaum | Q40173515 |
| P2093 | author name string | Min Wan | |
| Danielle N Gross | |||
| P2860 | cites work | Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma | Q24294948 |
| Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity | Q24298021 | ||
| Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation | Q24307581 | ||
| A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange | Q24648525 | ||
| SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation | Q24674602 | ||
| A Foxo/Notch pathway controls myogenic differentiation and fiber type specification | Q24678520 | ||
| Functional interaction between beta-catenin and FOXO in oxidative stress signaling | Q28115106 | ||
| SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma | Q28301961 | ||
| FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice | Q28507512 | ||
| The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth | Q28508976 | ||
| Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice | Q28511006 | ||
| Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake | Q28576714 | ||
| FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells | Q29614482 | ||
| FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
| Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 | ||
| A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose | Q30437005 | ||
| O-GlcNAc regulates FoxO activation in response to glucose | Q30439420 | ||
| Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation | Q34089899 | ||
| The forkhead transcription factor Foxo1 regulates adipocyte differentiation | Q34170890 | ||
| FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. | Q34521158 | ||
| The role of FoxO in the regulation of metabolism. | Q34768157 | ||
| The WNT signalling pathway and diabetes mellitus | Q34807472 | ||
| Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism | Q34945194 | ||
| Wnt signaling regulates pancreatic beta cell proliferation | Q35741102 | ||
| Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors | Q36325079 | ||
| Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components | Q36509759 | ||
| FoxO transcription factors in the maintenance of cellular homeostasis during aging | Q36663162 | ||
| Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells | Q36977666 | ||
| The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. | Q37120241 | ||
| Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism | Q37149810 | ||
| FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts | Q39735706 | ||
| Codependent activators direct myoblast-specific MyoD transcription | Q39929531 | ||
| Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity | Q40016533 | ||
| Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure | Q40030179 | ||
| Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. | Q40122836 | ||
| Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors | Q40248450 | ||
| Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis | Q40265984 | ||
| Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. | Q40301333 | ||
| The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation | Q40352430 | ||
| FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction | Q40375222 | ||
| FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. | Q40493379 | ||
| Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways | Q40635898 | ||
| Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation | Q42009070 | ||
| Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling | Q42800302 | ||
| Role of FoxO1 in FFA-induced oxidative stress in adipocytes | Q42829984 | ||
| The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity | Q42871294 | ||
| Monitoring FoxO1 localization in chemically identified neurons | Q43210742 | ||
| Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. | Q44666328 | ||
| Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control | Q44991663 | ||
| Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding | Q46510044 | ||
| PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response | Q46658340 | ||
| FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression | Q46955933 | ||
| Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver | Q48386175 | ||
| Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. | Q51495612 | ||
| FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle | Q56743003 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 208-214 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | The role of FOXO in the regulation of metabolism. | |
| P478 | volume | 9 |
| Q49389234 | 4-hydroxy-3-methoxycinnamic acid regulates orexigenic peptides and hepatic glucose homeostasis through phosphorylation of FoxO1. |
| Q89474658 | A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism |
| Q35600773 | A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism |
| Q36192550 | A load of mice to hypergravity causes AMPKα repression with liver injury, which is overcome by preconditioning loads via Nrf2. |
| Q36756228 | AMP-activated protein kinase and its downstream transcriptional pathways |
| Q51296770 | ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells. |
| Q28242180 | Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways |
| Q37525730 | Akt-mediated foxo1 inhibition is required for liver regeneration. |
| Q52607535 | Akt2: a critical regulator of cardiomyocyte survival and metabolism. |
| Q34173547 | Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats |
| Q34326755 | An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression. |
| Q87973497 | BMAL1 functions as a cAMP-responsive coactivator of HDAC5 to regulate hepatic gluconeogenesis |
| Q33734679 | Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis |
| Q33993073 | Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway |
| Q51295558 | Binge Alcohol Intake After Hypergravity Stress Sustainably Decreases AMPK and Transcription Factors Necessary for Hepatocyte Survival. |
| Q50290643 | Cardiac Development and Transcription Factors: Insulin Signalling, Insulin Resistance, and Intrauterine Nutritional Programming of Cardiovascular Disease |
| Q47712177 | Changes in the levels and phosphorylation status of Akt, AMPK, CREB and FoxO1 in hypothalamus of rainbow trout under conditions of enhanced glucosensing activity |
| Q91937435 | Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model |
| Q58599983 | Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments |
| Q51128779 | Crystal structures reveal a new and novel FoxO1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter. |
| Q55340375 | Dendrobium mixture regulates hepatic gluconeogenesis in diabetic rats via the phosphoinositide-3-kinase/protein kinase B signaling pathway. |
| Q35094215 | Developmental regulation of key gluconeogenic molecules in nonhuman primates |
| Q45801867 | Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1. |
| Q36130010 | Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet |
| Q90289927 | Ethanol-Induced Hepatic Insulin Resistance is Ameliorated by Methyl Ferulic Acid Through the PI3K/AKT Signaling Pathway |
| Q90405706 | FOXO transcription factors in non-alcoholic fatty liver disease |
| Q34415342 | FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease |
| Q91551847 | Fatty liver diseases, mechanisms, and potential therapeutic plant medicines |
| Q35163781 | Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice |
| Q26772751 | Fibroblast Growth Factor Signaling in Metabolic Regulation |
| Q35338937 | Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis |
| Q36964902 | Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study |
| Q37234039 | FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes |
| Q38069459 | FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival |
| Q34506666 | FoxO1 signaling plays a pivotal role in the cardiac telomere biology responses to calorie restriction |
| Q28080095 | FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification |
| Q35067314 | Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells |
| Q35780769 | Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus |
| Q45052537 | Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4. |
| Q37311340 | Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver |
| Q36419236 | Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition |
| Q35484801 | Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance |
| Q33840333 | Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model |
| Q34032001 | Insulin stimulates human skeletal muscle protein synthesis via an indirect mechanism involving endothelial-dependent vasodilation and mammalian target of rapamycin complex 1 signaling |
| Q45350737 | Isocaloric intake of a high-fat diet promotes insulin resistance and inflammation in Wistar rats |
| Q29543116 | Leucine signaling in the pathogenesis of type 2 diabetes and obesity |
| Q26800264 | Linking diet to acne metabolomics, inflammation, and comedogenesis: an update |
| Q40313842 | Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity |
| Q34255390 | MAPK signalling in cellular metabolism: stress or wellness? |
| Q36004187 | Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment |
| Q37699927 | Metabolism in T cell activation and differentiation |
| Q37088373 | MicroRNAs in metabolic disease |
| Q36435220 | Musclin is an activity-stimulated myokine that enhances physical endurance |
| Q35730880 | Neuregulin 1 Improves Glucose Tolerance in db/db Mice |
| Q35559692 | Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats |
| Q33618341 | Novel effects of Brefeldin A (BFA) in signaling through the insulin receptor (IR) pathway and regulating FoxO1-mediated transcription |
| Q26771411 | Osteocalcin as a hormone regulating glucose metabolism |
| Q90429880 | PTEN: Tumor Suppressor and Metabolic Regulator |
| Q54603582 | Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. |
| Q54300837 | Parallel down-regulation of FOXO1, PPARγ and adiponectin mRNA expression in visceral adipose tissue of class III obese individuals. |
| Q38666646 | Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c |
| Q37101729 | Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne |
| Q37175510 | Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats |
| Q44430905 | Quantity of glucose transporter and appetite-associated factor mRNA in various tissues after insulin injection in chickens selected for low or high body weight |
| Q90013024 | Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle |
| Q38230799 | Relevance of microRNA in metabolic diseases. |
| Q64916831 | Resolving the Paradox of Hepatic Insulin Resistance. |
| Q59792458 | Role of Overexpressed Transcription Factor FOXO1 in Fatal Cardiovascular Septal Defects in Patau Syndrome: Molecular and Therapeutic Strategies |
| Q35055513 | Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice |
| Q36220473 | Role of transcription factor acetylation in the regulation of metabolic homeostasis |
| Q40906113 | Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect |
| Q53689223 | Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. |
| Q34789391 | Survival response to increased ceramide involves metabolic adaptation through novel regulators of glycolysis and lipolysis |
| Q39578579 | Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene |
| Q34514818 | Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models |
| Q47253033 | The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism. |
| Q38121538 | The Role of PTEN in β-Cell Growth. |
| Q42113466 | The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance |
| Q64057750 | The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway |
| Q90633242 | Transcriptional Regulation of Energy Metabolism in Cancer Cells |
| Q33867427 | Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation |
| Q39246859 | Unraveling the Regulation of Hepatic Metabolism by Insulin |
| Q34127422 | Update of human and mouse forkhead box (FOX) gene families |
| Q35138570 | Wnt signaling regulates hepatic metabolism |
| Q59804839 | lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression |
Search more.